Naik Gautam, Wadiwala Ishaq, Hiremath Niranjan
Department of Cardiology, Indraprastha Apollo Hospital, Sarita Vihar, Delhi Mathura Road, New Delhi, 110076, DL, India.
Surat Municipal Institute of Medical Education and Research (SMIMER), Surat, India.
Curr Cardiol Rep. 2025 Jul 21;27(1):115. doi: 10.1007/s11886-025-02260-5.
This review explores the intercontinental disparities in endovascular treatment for aortic diseases, focusing on North America, Europe, Africa and Asia with special focus Southeast Asia(India). It highlights device availability, cost, accessibility, patient outcomes, and the necessity for improved healthcare equity.
The management of aortic diseases such as aneurysms and dissections has improved with endovascular techniques like thoracic endovascular aortic repair and fenestrated-branched repair. These minimally invasive procedures offer benefits over traditional surgery, including lower morbidity and mortality rates, reduced hospital stays, faster recovery times, and generally higher patient satisfaction. However, their adoption varies across continents due to differences in healthcare infrastructure, economic resources, regulatory environments, and physician expertise. By examining the current landscape of endovascular aortic treatment globally, we can better understand the challenges and opportunities for enhancing aortic care and ensuring equitable access for all patients, regardless of their geographic location and socioeconomic status.
本综述探讨主动脉疾病血管内治疗的洲际差异，重点关注北美、欧洲、非洲和亚洲，特别聚焦东南亚（印度）。它强调了设备可用性、成本、可及性、患者预后以及改善医疗公平性的必要性。
诸如动脉瘤和夹层等主动脉疾病的管理已通过胸主动脉腔内修复术和开窗分支修复术等血管内技术得到改善。这些微创手术相对于传统手术具有诸多优势，包括更低的发病率和死亡率、缩短住院时间、更快的恢复时间以及总体上更高的患者满意度。然而，由于医疗基础设施、经济资源、监管环境和医生专业知识的差异，这些技术在各大洲的采用情况各不相同。通过审视全球范围内主动脉腔内治疗的现状，我们能够更好地理解在加强主动脉疾病治疗以及确保所有患者无论地理位置和社会经济地位如何都能公平获得治疗方面所面临的挑战和机遇。
